Abeona Therapeutics (ABEO): Congress and insider trades
Who in Congress and inside the company traded ABEO, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Abeona Therapeutics (ABEO) is a listed stock on NASDAQ.
- Insiders filed 0 open market buys worth $0 and 18 sells worth $1.9M, the latest filed 2026-09-01 (1 September 2026).
- Data as of 2026-09-29 (29 September 2026).
Insider trades in ABEO
as of 2026-09-01| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 1 Sep 2026 | Alvino Mark | sell | 15,000 | $5.86 | $88.0K | n/a |
| 22 Jul 2026 | Vazzano Joseph Walter | sell | 1,478 | $6.53 | $9.7K | n/a |
| 9 Jul 2026 | Vasanthavada Madhav | sell | 12,606 | $6.96 | $87.8K | n/a |
| 9 Jul 2026 | O'Malley Brendan M. | sell | 12,050 | $6.96 | $83.9K | n/a |
| 9 Jul 2026 | Vazzano Joseph Walter | sell | 24,880 | $6.96 | $173K | n/a |
| 9 Jul 2026 | Seshadri Vishwas | sell | 67,971 | $6.96 | $473K | n/a |
| 2 Jul 2026 | Alland Leila | sell | 11,000 | $5.92 | $65.1K | n/a |
| 15 Jun 2026 | Silverstein Christine Berni | sell | 18,160 | $5.71 | $104K | n/a |
| 9 Jun 2026 | O'Malley Brendan M. | sell | 6,305 | $5.30 | $33.4K | n/a |
| 9 Jun 2026 | Vasanthavada Madhav | sell | 5,450 | $5.30 | $28.9K | n/a |
| 9 Jun 2026 | O'Malley Brendan M. | sell | 4,826 | $5.43 | $26.2K | n/a |
| 9 Jun 2026 | Vazzano Joseph Walter | sell | 10,271 | $5.43 | $55.8K | n/a |
| 9 Jun 2026 | Seshadri Vishwas | sell | 24,428 | $5.43 | $133K | n/a |
| 9 Jun 2026 | Vazzano Joseph Walter | sell | 39,067 | $5.36 | $209K | n/a |
| 9 Jun 2026 | Seshadri Vishwas | sell | 31,916 | $5.30 | $169K | n/a |
| 9 Jun 2026 | Vasanthavada Madhav | sell | 4,170 | $5.43 | $22.6K | n/a |
| 22 May 2026 | Alvino Mark | sell | 6,500 | $5.46 | $35.5K | n/a |
| 31 Mar 2026 | Seshadri Vishwas | sell | 29,985 | $4.38 | $131K | n/a |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought ABEO?
0 Congress buys by 0 members and 0 insider buys are on file. The tables on this page list every one.
Did buying ABEO after a disclosure beat the market?
No disclosed buy of this stock has matured 90 days yet. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.